Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

System interactions.

Mervyn Singer1

  • 1Bloomsbury Institute of Intensive Care Medicine, Dept of Medicine and Wolfson Institute of Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK.

Novartis Foundation Symposium
|March 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct lymphocyte immune signatures to nivolumab and recombinant IL-7 ex vivo in patients with sepsis.

Journal of leukocyte biology·2026
Same author

Current knowledge and challenges of sepsis-associated encephalopathy.

Intensive care medicine·2026
Same author

Evaluation of plasma calprotectin as a marker for infection in various clinical settings: a prospective observational study.

Intensive care medicine experimental·2026
Same author

Deranged mitochondrial metabolism in critical illness: how to fill the gap between preclinical knowledge and clinical application.

Intensive care medicine·2026
Same author

Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM).

Critical care medicine·2026
Same author

Clinical criteria for the definition of refractory septic shock: a joint Delphi consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM).

Intensive care medicine·2026
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

Sepsis involves more than inflammation; it affects neural, immune, and metabolic systems. Understanding these complex interactions is key to improving patient outcomes and reducing harm from treatments.

Area of Science:

  • Critical care medicine
  • Systems biology
  • Infectious disease

Background:

  • Sepsis is traditionally viewed as an overactive inflammatory response to infection.
  • Emerging evidence suggests sepsis involves widespread dysregulation across multiple physiological systems.

Purpose of the Study:

  • To broaden the understanding of sepsis beyond inflammation.
  • To highlight the involvement of neural, immune, hormonal, bioenergetic, and metabolic pathways in sepsis.
  • To emphasize the need for a systems-level approach to sepsis management.

Main Methods:

  • Review and synthesis of current literature on sepsis pathophysiology.
  • Analysis of the multi-systemic impact of sepsis.
  • Exploration of temporal dynamics and interactions between affected pathways.

Related Experiment Videos

Main Results:

  • Sepsis activates or depresses neural, immune, hormonal, bioenergetic, and metabolic pathways.
  • Systemic pathway perturbations correlate with increased mortality risk.
  • The interplay and timing of these pathway changes are not well understood.

Conclusions:

  • Sepsis requires a paradigm shift towards a multi-systemic view.
  • Improved understanding of these complex networks can refine interventions.
  • Minimizing iatrogenic harm from standard therapies is crucial for reducing sepsis mortality.